行情

AVDL

AVDL

Avadel
NASDAQ

实时行情|Nasdaq Last Sale

7.10
-0.43
-5.71%
交易中 13:48 01/24 EST
开盘
7.49
昨收
7.53
最高
7.55
最低
6.93
成交量
61.07万
成交额
--
52周最高
8.49
52周最低
1.030
市值
2.66亿
市盈率(TTM)
-2.7890
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AVDL 新闻

  • 午盘:制造业PMI不及预期 美股下跌道指跌近100点
  • 新浪美股.1小时前
  • 数据显示Apple TV+四季度美国订阅用户达3360万
  • 新浪美股.2小时前
  • 迪斯尼+大获成功 大摩上调迪士尼目标价至170美元
  • 新浪美股.2小时前
  • 尚乘蔡志坚:数字化将进一步推动可持续发展
  • 新浪财经.2小时前

更多

所属板块

制药
-1.55%
制药与医学研究
-1.71%

热门股票

名称
价格
涨跌幅

AVDL 简况

Avadel Pharmaceuticals, PLC is a specialty pharmaceutical company. The Company offers various drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. The Company offers its products in various categories, including hospital, including Bloxiverz, Vazculep and Akovaz, and pediatrics, including Karbinal ER, Cefaclor for Oral Suspension, AcipHex Sprinkle and Flexichamber. Bloxiverz is a drug used intravenously in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Vazculep is used to treat clinically hypotension resulting primarily from vasodilation in the setting of anesthesia. Akovaz is indicated to treat clinically hypotension in the setting of anesthesia. Cefaclor is indicated for the treatment of otitis media, lower respiratory infections, pharyngitis and tonsillitis, urinary tract infections, and skin and skin structure infections, caused by susceptible organisms.
展开

Webull提供Avadel Pharmaceuticals PLC (ADR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。